A - Human Necessities – 61 – K
Patent
A - Human Necessities
61
K
A61K 38/48 (2006.01) C12N 9/48 (2006.01) C12N 15/57 (2006.01) A61K 38/00 (2006.01) A61K 39/00 (2006.01)
Patent
CA 2468501
The invention in particular relates to the modification of a bacterial enzyme carboxypeptidease G2 (CPG2) to result in CPG2 proteins that are substantially non-immunogenic or less immunogenic than any non-modified counterpart when used in vivo. The present invention relates also to T-cell epitope peptides derived from said non-modified protein by means of which it is possible to create modified CPG2 variants with reduced immunogenicity. These polypeptides are suitable particularly for therapeutic use in humans.
L'invention concerne la modification d'une carboxypeptidease G2 (CPG2) d'une enzyme bactérienne en protéines CPG2 qui sont pratiquement non immunogènes ou moins immunogènes que tout homologue non modifié, lors d'une utilisation in vivo. Cette invention a également trait à des peptides d'épitopes de lymphocytes T dérivés de ladite protéine non modifiée, au moyen desquels il est possible de créer des variants CPG2 modifiés à immunogénicité réduite. Ces polypeptides sont notamment appropriés à une utilisation thérapeutique chez des êtres humains.
Baker Matthew
Carr Francis J.
Hellendoorn Koen
Williams Steven
Fetherstonhaugh & Co.
Merck Patent Gesellschaft Mit Beschraenkter Haftung
LandOfFree
T-cell epitodes in carboxypeptidase g2 does not yet have a rating. At this time, there are no reviews or comments for this patent.
If you have personal experience with T-cell epitodes in carboxypeptidase g2, we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and T-cell epitodes in carboxypeptidase g2 will most certainly appreciate the feedback.
Profile ID: LFCA-PAI-O-1432227